Patents by Inventor Kurt M. Poindexter

Kurt M. Poindexter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of integrin antagonists to inhibit angiogenesis
    Patent number: 7074408
    Abstract: The present invention provides methods and compositions for inhibiting the biological activity of integrins, for inhibiting endothelial cell migration. and for inhibiting angiogenesis. In particular, the invention provides compositions comprising ADAM disintegrin domains and methods for using said compositions. In preferred embodiments the methods and compositions of the invention are used to inhibit angiogenesis and to treat diseases or conditions mediated by angiogenesis.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: July 11, 2006
    Assignee: Immunex Corporation
    Inventors: William C. Fanslow, III, Douglas P. Cerretti, Kurt M. Poindexter, Roy A. Black
  • Human disintegrin protein
    Publication number: 20040047854
    Abstract: Provided is a new disintegrin polypeptide, methods of making such polypeptides, and methods of using them to treat disintegrin-associated disorders and conditions and to identify agents that modulate Metalloproteinase-Disintegrin polypeptide activities.
    Type: Application
    Filed: June 10, 2003
    Publication date: March 11, 2004
    Inventors: Roy A. Black, Kurt M. Poindexter, Bruce A. Mosley, Robert F. DuBose, Steven R. Wiley
  • Integrin antagonists
    Publication number: 20020042368
    Abstract: The present invention provides methods and compositions for inhibiting the biological activity of integrins, for inhibiting endothelial cell migration. and for inhibiting angiogenesis. In particular, the invention provides compositions comprising ADAM disintegrin domains and methods for using said compositions. In preferred embodiments the methods and compositions of the invention are used to inhibit angiogenesis and to treat diseases or conditions mediated by angiogenesis.
    Type: Application
    Filed: February 23, 2001
    Publication date: April 11, 2002
    Inventors: William C. Fanslow, Douglas P. Cerretti, Kurt M. Poindexter, Roy A. Black